Evexia adds Vitae Diagnostics' EAT144 food immune reactivity test

Evexia Diagnostics has added Vitae Diagnostics' EAT144 to its specialty testing lineup, giving functional and integrative medicine practitioners access to a five-pathway food immune reactivity assessment. The test is designed to expand clinical insight into food-related immune responses through both at-home and lab-based collection options.

Why it matters: - EAT144 gives clinicians a broader view of food-related immune activity than traditional tests that focus on one or two markers. - The added access through Evexia Diagnostics expands availability for functional and integrative medicine practices that use specialty laboratory testing to guide individualized care. - The test is designed to support nutrition and lifestyle recommendations with a more detailed immune profile.

What happened: - Evexia Diagnostics added Vitae Diagnostics' EAT144 Food Immune Reactivity Test to its specialty diagnostic portfolio. - The announcement was made Oct. 6, 2026. - The test is now available through the Evexia Diagnostics platform. - The launch is aimed at healthcare practitioners in functional and integrative medicine.

The details: - EAT144 measures five immune pathways: IgE, IgG, IgG4, IgA and C3bd complement. - The test is built to assess immune responses to foods across multiple pathways in a single report. - Results are presented in a color-coded format designed to be easy to read and interpret. - The report is intended to help clinicians identify potential food immune reactions and turn findings into individualized recommendations. - EAT144 is available through at-home collection kits. - EAT144 is also available through traditional blood draw collection at participating laboratory locations. - Vitae Diagnostics says the test was developed to give clinicians a more complete picture of food-related immune activity. - Evexia Diagnostics says the addition fits its mission of delivering practical diagnostic tools that support personalized patient care. - Vitae Diagnostics says the reporting format is intended to reduce the time practitioners spend interpreting lab data. - Vitae Diagnostics says the test supports individualized care strategies.

Between the lines: - The launch reflects growing demand for precision nutrition tools in functional medicine. - The five-pathway design positions EAT144 as a more comprehensive option in a crowded food sensitivity testing market. - Flexible collection options lower friction for both clinics and patients, which can make specialty testing easier to adopt. - The focus on simple reporting suggests the companies are targeting clinicians who want advanced data without adding complexity.

What's next: - Clinicians using Evexia Diagnostics can begin ordering EAT144 through the platform. - Wider use of the test will likely depend on how practitioners respond to the collection options and report format. - Both companies are positioning the product for broader adoption as interest in individualized healthcare continues to grow.

The bottom line: - Evexia's addition of EAT144 gives practitioners a more detailed food immune reactivity test with flexible collection and clinician-friendly reporting.